Founded in 1856, Smith & Nephew Plc is a UK-based multinational medical equipment manufacturing company, engaged in designing and manufacturing of technology that takes the limits off living. The company offers advanced wound management products, trauma and clinical therapy products, arthroscopy products and orthopaedic reconstruction products. It operates in over 100 countries across Americas, Asia, Africa, Europe, Australasia, and Middle East. The company is listed on the London Stock Exchange as LON: SN. And is a constituent of the FTSE 100 Index. It is also listed on the New York Stock Exchange as NYSE: SNN.
The company supports healthcare professionals to return their patients to health and mobility, helping them to perform at their fullest potential. The company operates through three segments that include Advanced wound management, Orthopaedics & Trauma and Sports Medicine. The Advanced wound management portfolio offers a comprehensive set of products to meet broad and complex clinical needs, to help healthcare professionals reduce the human and economic consequences of wounds.
The company’s Orthopaedics products offer an innovative range of Hip and Knee Implants used to replace diseased, robotics-assisted enabling technologies that empower surgeons, damaged or worn joints, and its Trauma products used to stabilize severe fractures and correct bone deformities. The company’s Sports Medicine and Ear, Nose and Throat (ENT) provide advanced products and instruments used to repair or remove soft tissue. it operates in growing markets where unmet clinical needs provide opportunities for procedural and technological innovation.
Building 5, Croxley Park, Hatters Lane, Watford, WD18 8YE, United Kingdom